Company Filing History:
6 out of 4,447 
6 out of 1,586 
Years Active: 2007-2016
Title: The Innovative Contributions of Ronald DeMattos
Introduction
Ronald DeMattos is a notable inventor based in Noblesville, IN (US), recognized for his significant contributions to the field of Alzheimer's disease research. With a total of 6 patents, his work focuses on diagnostic methods and therapeutic approaches to combat this debilitating condition.
Latest Patents
Among his latest patents is an assay method for Alzheimer's disease, which provides a diagnostic test for both preclinical and clinical stages of the disease. This method is based on measuring plasma levels of amyloid beta (Aβ), their ratio, or their rate of entry following the administration of antibodies that sequester Aβ. Any alterations in these parameters from control values can identify preclinical or clinical Alzheimer's disease. Another significant patent involves humanized antibodies that sequester amyloid beta peptide. This method aims to treat conditions characterized by the formation of amyloid plaques, both prophylactically and therapeutically, using humanized antibodies that specifically bind to an epitope within positions 13-28 of the amyloid beta peptide Aβ.
Career Highlights
Throughout his career, Ronald DeMattos has worked with prominent organizations, including Eli Lilly and Company and Washington University. His innovative research has contributed to advancements in understanding and treating Alzheimer's disease.
Collaborations
Ronald has collaborated with esteemed colleagues such as David Michael Holtzman and Kelly R Bales, further enhancing the impact of his work in the scientific community.
Conclusion
In summary, Ronald DeMattos is a distinguished inventor whose work in Alzheimer's disease research has led to valuable patents and collaborations. His contributions continue to pave the way for advancements in diagnostics and treatment options for this challenging condition.